v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid in Capital
Retained Earnings
Cumulative effect of change in accounting principle - Current Expected Credit Losses
Retained Earnings
Unallocated Common Stock of ESOP
Accumulated Other Comprehensive Income (Loss)
Cumulative effect of change in accounting principle - Current Expected Credit Losses
Total
Balance at beginning of period at Jun. 30, 2023 $ 260 $ 113,543 $ 507 $ 173,038 $ (10,573) $ (9,568) $ 507 $ 266,700
Balance at beginning of period (in shares) at Jun. 30, 2023 25,977,679              
Increase (Decrease) in Shareholder's Equity                
Net income               6,611
Other comprehensive income               9,749
Balance at end of period at Dec. 31, 2023           181    
Balance at beginning of period at Jun. 30, 2023 $ 260 113,543 $ 507 173,038 (10,573) (9,568) $ 507 266,700
Balance at beginning of period (in shares) at Jun. 30, 2023 25,977,679              
Increase (Decrease) in Shareholder's Equity                
Net income       15,260       15,260
Other comprehensive income           14,510   14,510
ESOP shares committed to be released   (209)     681     472
Stock-based compensation expense   154           154
Restricted stock awards granted $ 4 (4)            
Restricted stock awards granted (in shares) 390,000              
Repurchases of common stock $ (1)     (1,074)       (1,075)
Repurchases of common stock (in shares) (106,386)              
Balance at end of period at Jun. 30, 2024 $ 263 113,484   187,731 (9,892) 4,942   296,528
Balance at end of period (in shares) at Jun. 30, 2024 26,261,293              
Increase (Decrease) in Shareholder's Equity                
Net income       9,600       9,600
Other comprehensive income           601   601
ESOP shares committed to be released   (58)     341     283
Stock-based compensation expense   687           687
Restricted stock awards granted (in shares) 5,000              
Repurchases of common stock $ (3)     (3,143)       (3,146)
Repurchases of common stock (in shares) (287,389)              
Balance at end of period at Dec. 31, 2024 $ 260 114,113   194,188 (9,551) 5,543   $ 304,553
Balance at end of period (in shares) at Dec. 31, 2024 25,978,904             25,978,904
Increase (Decrease) in Shareholder's Equity                
Net income       20,287       $ 20,287
Other comprehensive income           8,490   8,490
ESOP shares committed to be released   (56)     683     627
Stock-based compensation expense   1,267           1,267
Restricted stock awards granted, net of forfeitures (in shares) 2,000              
Purchase of employee restricted shares to fund statutory tax withholdings       (145)       (145)
Purchase of employee restricted shares to fund statutory tax withholdings (in shares) (12,300)              
Stock options exercised, net   76           $ 76
Stock options exercised, net (shares) 8,718             10,500
Repurchases of common stock $ (9)     (11,285)       $ (11,294)
Repurchases of common stock (in shares) (905,108)              
Balance at end of period at Dec. 31, 2025 $ 251 $ 115,400   $ 203,045 $ (8,868) $ 14,033   $ 323,861
Balance at end of period (in shares) at Dec. 31, 2025 25,072,214             25,072,214